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Abstract
In addition to their well-defined roles in replenishing depleted endoplasmic reticulum (ER) Ca
2+ reserves, molecular
components of the store-operated Ca
2+ entry pathway regulate breast cancer metastasis. A process implicated in cancer
metastasis that describes the conversion to a more invasive phenotype is epithelial-mesenchymal transition (EMT). In this
study we show that EGF-induced EMT in MDA-MB-468 breast cancer cells is associated with a reduction in agonist-
stimulated and store-operated Ca
2+ influx, and that MDA-MB-468 cells prior to EMT induction have a high level of non-
stimulated Ca
2+ influx. The potential roles for specific Ca
2+ channels in these pathways were assessed by siRNA-mediated
silencing of ORAI1 and transient receptor potential canonical type 1 (TRPC1) channels in MDA-MB-468 breast cancer cells.
Non-stimulated, agonist-stimulated and store-operated Ca
2+ influx were significantly inhibited with ORAI1 silencing. TRPC1
knockdown attenuated non-stimulated Ca
2+ influx in a manner dependent on Ca
2+ influx via ORAI1. TRPC1 silencing was
also associated with reduced ERK1/2 phosphorylation and changes in the rate of Ca
2+ release from the ER associated with
the inhibition of the sarco/endoplasmic reticulum Ca
2+-ATPase (time to peak [Ca
2+]CYT=188.7634.6 s (TRPC1 siRNA) versus
124.069.5 s (non-targeting siRNA); P,0.05). These studies indicate that EMT in MDA-MB-468 breast cancer cells is
associated with a pronounced remodeling of Ca
2+ influx, which may be due to altered ORAI1 and/or TRPC1 channel
function. Our findings also suggest that TRPC1 channels in MDA-MB-468 cells contribute to ORAI1-mediated Ca
2+ influx in
non-stimulated cells.
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Introduction
Plasma membrane Ca
2+ channels, including voltage-gated,
transient receptor potential (TRP), and store-operated Ca
2+
channels, regulate Ca
2+ influx in a highly controlled and cell
type-dependent manner to regulate specific cellular processes. For
example rapid Ca
2+ influx through voltage-gated Ca
2+ channels at
the neurological synapse regulates the exocytosis of neurotrans-
mitters from presynaptic neurons [1]. An influx pathway
increasingly recognized as a regulator of intracellular signaling
processes in epithelial cells is store-operated Ca
2+ entry [2–4]. The
molecular components for this influx pathway, which is respon-
sible for replenishing endoplasmic reticulum (ER) Ca
2+ reserves
following Ca
2+ store depletion, include the store-operated Ca
2+
channel pore-forming subunits ORAI1, ORAI2 and ORAI3 [5–7]
and their classical activators the ER Ca
2+ sensors STIM1 and
STIM2 [8,9]. Activation of ORAI1-mediated Ca
2+ influx by other
proteins has also been identified; this includes regulation by pre-
STIM2 [10] and SPCA2 [11], the latter of which is a Ca
2+ store-
independent mechanism important in some breast cancers.
Although ORAI proteins are now recognized as the central
components of store-operated Ca
2+ entry, the canonical-type TRP
channels (TRPCs), in particular TRPC1, are also reported to
interact with STIM proteins and in some cell types appear to
regulate agonist-stimulated and store-operated Ca
2+ entry [4,12].
Mechanisms governing the pathways involved in replenishing ER
Ca
2+ reserves, such as the ion channels involved and their
activation, may therefore be context-dependent and vary between
cell types.
In breast cancer cells, ORAI1 regulates processes important for
carcinogenesis and is enriched in some breast cancer cell lines
relative to non-tumorigenic breast epithelial cells [13]. Knock-
down of ORAI1 is anti-proliferative in MCF7 breast cancer cells
and is associated with reduced activity of extracellular signal-
regulated kinase (ERK1/2) [11]. Furthermore, inhibition of
ORAI1 in invasive MDA-MB-231 breast cancer cells reduces
serum-induced migration in vitro and metastasis formation in vivo
[14].
A process implicated in breast cancer metastasis is the transition
from an epithelial state to a more invasive mesenchymal
phenotype, termed epithelial-mesenchymal transition (EMT)
[15]. This phenotypic switch involves changes in cell morphology,
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36923expression of the type III intermediate filament vimentin, and the
production and secretion of proteases at the leading edge to
facilitate invasion [15,16].
A cellular conversion comparable to EMT that is particularly
important in atherosclerotic vascular disease, involves the trans-
formation of vascular smooth muscle cells from a contractile
(quiescent) to a synthetic (proliferative) phenotype [17]. This
change is associated with a remodeling of Ca
2+ influx pathways,
including elevated store-operated Ca
2+ entry [18]. In breast cancer
cells, Ca
2+ signaling requirements are also likely to differ as cells
undergo EMT and transition from an epithelial phenotype to a
mesenchymal state. Indeed, EGF-induced EMT in MDA-MB-468
breast cancer cells is associated with a remodeling of purinergic
receptor-mediated Ca
2+ signaling [19] and transforming growth
factor b (TGFb)-induced EMT in MCF7 breast cancer cells has
been reported to be associated with increased store-operated Ca
2+
influx [20]. Here we sought to assess changes in store-operated
Ca
2+ entry in a well characterized model of EMT mediated by
EGF in MDA-MB-468 breast cancer cells. A greater understand-
ing of the changes in Ca
2+ influx associated with EMT in breast
cancer cells may help identify novel therapeutic targets for the
control of breast cancer metastasis.
Materials and Methods
Cell culture and reagents
MDA-MB-468 [19] and MDA-MB-231 [21] human breast
cancer cells were cultured in DMEM (D6546, Sigma Aldrich)
containing 10% fetal bovine serum (FBS), 4 mM L-glutamine,
100 U/mL penicillin and 100 mg/mL streptomycin. Cells were
maintained in a humidified 37uC incubator with 5% CO2 and were
routinely screened for mycoplasma contamination (MycoAlert,
Lonza).Cyclopiazonicacid(CPA),trypsinand ATPwerepurchased
from Sigma Aldrich. Fluo-4 AM and BAPTA were purchased from
Invitrogen. TaqMan Gene Expression Assays (Applied Biosystems)
included: human Twist1 (Hs00361186_m1), Snail (Hs00195591
_m1), fibronectin (Hs01549976_m1), vimentin (Hs00185584_m1),
ORAI1 (Hs00385627_m1) and TRPC1 (Hs01553152_m1). Dhar-
macon On-TARGET plus SMARTpool
TM siRNAs were used at a
final concentration of 100 nM: non-targeting (D-001810-10-05),
TRPC1 (L-004191-00-0005) and ORAI1 (L-014998-00-0005). The
following Cell Signaling antibodies were used: mouse monoclonal
anti-phospho-ERK1/2 (Thr202/Tyr204; 9106) at 1:2000 and
rabbit polyclonal anti-ERK1/2 (9102) at 1:1000, incubated
overnight; and from BioRad, anti-mouse horseradish peroxidase-
conjugated and anti-rabbit horseradish peroxidase-conjugated
secondary antibodies (1:10,000).
Measurement of intracellular calcium
Global cytosolic Ca
2+ responses in MDA-MB-468 and MDA-
MB-231 cells were assessed using a fluorometric imaging plate
reader (FLIPR
TETRA, Molecular Devices). MDA-MB-468 breast
cancer cells were seeded at 3610
4 cells/well in 96-well microplates
(Corning Costar). Cells were serum-deprived (0.5% FBS, 24 h)
(Fig. 1, 2 & 3), and treated 6 EGF (50 ng/mL, 24 h) as indicated
(Fig. 2 & 3) [19,22]. For Ca
2+ assays in siRNA-transfected MDA-
MB-468 cells a seeding density of 1.5610
4 cells/well was used and
4610
3 cells/well for MDA-MB-231 cells. Cells were loaded for
1 h at 37uC with 2 mM Fluo-4 AM Ca
2+ indicator in a solution
containing 500 mM probenecid and 5% (v/v) PBX Signal
Enhancer (BD Biosciences) in physiological salt solution (PSS;
5.9 mM KCl, 1.4 mM MgCl2, 10 mM HEPES, 1.2 mM
NaH2PO4, 5 mM NaHCO3, 140 mM NaCl, 11.5 mM glucose
and 1.8 mM CaCl2) [21]. Cells were allowed to equilibrate to
room temperature (15 min) and loading solution was then
replaced with a solution containing 500 mM probenecid and 5%
(v/v) PBX Signal Enhancer in nominally Ca
2+-free PSS.
Intracellular Ca
2+ measurements were performed with 470/95
and 515/75 nm excitation and emission filters. Data analysis was
performed using ScreenWorks Software (v2.0.0.27, Molecular
Devices). The ratio of influx to store release was calculated as
follows: [peak 2 amplitude/peak 1 area under the curve
(AUC)]*1000. The % reduction in Ca
2+ influx (e.g., % reduction
of non-stimulated Ca
2+ influx with siORAI1) was calculated by
first subtracting the baseline, as follows: [(siNT peak 2 amplitude
21)/(siORAI1 peak 2 amplitude 21)]*100%.
For live cell imaging of Ca
2+ oscillations, MDA-MB-468 cells
were grown to confluency and cells were loaded with Fluo-4 AM
as described above. Images were acquired using a Nikon Eclipse
TE 300 inverted epifluorescence microscope with a 406 oil
objective and 488/550 nm excitation/emission wavelengths. A
33 ms exposure time and 262 binning was used; images were
acquired every 5 s for approximately 120 cycles prior and
subsequent to BAPTA (1.7 mM) addition.
Real time RT-PCR
For quantitation of changes in gene expression as a consequence
of EGF-induced EMT, MDA-MB-468 cells were plated in 6-well
plates at seeding density of 8.5610
4 cells/well. Cells were serum
deprived and treated with EGF (50 ng/mL) for 12 h. Total RNA
was isolated using the Qiagen RNeasy Mini Kit. Omniscript RT
(Qiagen) was used for reverse transcription and resulting cDNA
was amplified using TaqMan Fast Universal PCR Master Mix
with TaqMan Gene Expression Assays.
siRNA transfection
Dharmacon ON-TARGETplus SMARTpool
TM siRNA was
used as per the manufacturer’s instructions. This product consists
of four rationally designed siRNAs with both sense and anti-sense
strand modification to reduce off-target effects [23]. MDA-MB-
468 cells were seeded at 1.5610
4 cells/well in antibiotic-free
media. DharmaFECT4 transfection reagent was used at a
concentration of 0.2 mL/well. Knockdown for Ca
2+ assays and
protein isolations was confirmed 48 h post-transfection as per
manufacturer’s instructions, given that changes in mRNA levels
are expected to precede changes in protein expression and
functional responses (assessed 96 h post-transfection).
Immunoblotting
Cell extracts were prepared using protein lysis buffer supple-
mented with protease and phosphatase inhibitors (Roche Applied
Science). Gel electrophoresis was performed under reduced
denatured conditions using 4–12% gradient Bis-Tris gels with
MOPS running buffer (Invitrogen), and transferred to PVDF
membranes. Membranes were blocked for 1 h at room temperature
using 5% (w/v) skim milk powder in phosphate buffered saline
(PBS) containing 0.1% (v/v) Tween-20. Bands were visualized with
chemiluminescence using Super-Signal West Dura substrate
(Thermo Fisher Scientific). Image acquisition was performed on a
VersaDoc Imaging System (BioRad) and quantitation using ImageJ
(v1.45 s, National Institutes of Health), as per the gel analysis
method outlined in the ImageJ documentation. Brightness and
contrast adjustment were applied uniformly to all gels.
Cell number and S-phase analysis
MDA-MB-468 cells were seeded in 96-well imaging plates (BD
Biosciences) at 5610
3 cells/well and treated with siRNA for 96 h.
TRPC1 and ORAI1 in MDA-MB-468 Cells
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(v/v) formaldehyde in PBS and permeabilized with 0.5% (v/v)
Triton X-100. Cells were then incubated with the Click-iT
reaction cocktail (Alexa Fluor 555; Invitrogen) for 30 min and
DAPI (400 nM) for 90 min. Cells were imaged with a 106
objective using the ImageXpress Micro automated epifluorescence
microscope (Molecular Devices) based on the following excitation
and emission wavelengths: 377/50 and 447/60 nm for DAPI and
531/40 and 593/40 for EdU (Cy3). Cell number and percentage
of EdU positive cells was measured using the multi-wavelength cell
scoring application module (MetaXpress v3.1.0.83; Molecular
Devices).
Statistical analysis
Statistical analysis was performed using GraphPad Prism (v5.03
for Windows). Statistical tests used in this study are outlined in
each figure legend.
Results
Non-stimulated calcium influx in MDA-MB-468 breast
cancer cells
We assessed agonist-stimulated and store-operated Ca
2+ entry
in MDA-MB-468 breast cancer cells compared to the previously
characterized MDA-MB-231 breast cancer cell line [13]. MDA-
MB-231 cells are considered more mesenchymal in nature than
MDA-MB-468 cells, which (in the absence of EMT inducers) are
in a more epithelial state [24]. MDA-MB-468 and MDA-MB-231
cells were treated with ATP (purinergic receptor agonist) or CPA
(a sarco/endoplasmic reticulum Ca
2+ ATPase (SERCA) inhibitor)
in nominally Ca
2+-free conditions, to assess ATP-stimulated Ca
2+
entry and store-operated Ca
2+ entry, respectively. ATP and CPA
both produced an initial (peak 1) transient increase in cytosolic free
Ca
2+ levels ([Ca
2+]CYT) and Ca
2+ influx (peak 2) following the re-
addition of extracellular Ca
2+ in MDA-MB-468 (Fig. 1A) and
MDA-MB-231 (Fig. 1B) cells. Significant Ca
2+ influx was observed
in the absence of agents to deplete ER Ca
2+ stores in MDA-MB-
468 cells (herein referred to as non-stimulated Ca
2+ influx; Fig. 1A).
Non-stimulated Ca
2+ influx was greater in MDA-MB-468 cells
(approximately 53% of the store-operated Ca
2+ entry response;
Fig. 1A & C) compared to MDA-MB-231 cells (non-stimulated
Ca
2+ influx approximately 3% of the store-operated Ca
2+ entry
response; Fig. 1B & D).
The greater non-stimulated Ca
2+ influx in MDA-MB-468 breast
cancer cells was associated with spontaneous Ca
2+ oscillations that
were attenuated upon removal of non-stimulated Ca
2+ influx
through extracellular Ca
2+ chelation with BAPTA (Fig. 1E). These
spontaneous Ca
2+ oscillations were asynchronous, as shown by the
Y-plane projection through time (Fig. 1F & G) and the
representative movie file (Movie S1). Ca
2+ oscillations appear to
Figure 1. Assessment of cytosolic Ca
2+ signaling in MDA-MB-468 and MDA-MB-231 breast cancer cell lines. Average ATP-stimulated
Ca
2+ entry response (100 mM ATP), store-operated Ca
2+ entry response (10 mM CPA) and non-stimulated Ca
2+ influx (DMSO control) were assessed in
A) MDA-MB-468 and B) MDA-MB-231 cells. Quantitation of peak relative Ca
2+ influx (peak 2) in C) MDA-MB-468 and D) MDA-MD-231 cells; shown as
average 6 S.D. (n=9 for MDA-MB-468 & n=4 for MDA-MB-231 cells). E) MDA-MB-468 cells exhibit spontaneous and asynchronous Ca
2+ oscillations
that are attenuated by extracellular Ca
2+ chelation (BAPTA). F) Still image showing the Y-plane section and G) the Y-plane projection through time.
See also Movie S1. Representative of five movies from three independent experiments.
doi:10.1371/journal.pone.0036923.g001
TRPC1 and ORAI1 in MDA-MB-468 Cells
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associated with their non-stimulated Ca
2+ influx. To our
knowledge this is the first study to report spontaneous Ca
2+
oscillations in MDA-MB-468 breast cancer cells and we have not
previously seen such spontaneous oscillations in other breast
cancer cell lines, however, assessment in MDA-MB-231 breast
cancer cells, which had a low level of non-stimulated Ca
2+ influx,
should be conducted and compared to MDA-MB-468 cells.
EGF-induced EMT attenuates non-stimulated calcium
influx in MDA-MB-468 breast cancer cells
To assess possible alterations in non-stimulated Ca
2+ influx
associated with EMT, MDA-MB-468 cells were treated with EGF,
a well characterized EMT inducer in this breast cancer cell line.
EGF produced significant increases in the EMT markers Twist,
Snail, fibronectin and vimentin (Fig. 2A–D). MDA-MB-468 breast
cancer cells undergoing EMT (herein referred to as MDA-MB-
468-EMT cells) exhibited reduced non-stimulated Ca
2+ influx
(Fig. 2E–G).
EGF-induced EMT is associated with a reduction in store-
operated and agonist-stimulated calcium entry
A reduction in ATP-mediated Ca
2+ influx (peak 2 amplitude)
was observed in MDA-MB-468-EMT cells (Fig. 3A & B). We
quantified the ratio of Ca
2+ influx relative to Ca
2+ store release
(i.e., peak 2 amplitude divided by peak 1 AUC) (Fig. 3C). These
Figure 2. Non-stimulated Ca
2+ influx in MDA-MB-468 cells induced to undergo EMT with EGF. MDA-MB-468 breast cancer cells
stimulated with EGF to induce EMT (MDA-MB-468-EMT) have elevated transcription of the mesenchymal markers A) Twist, B) Snail, C) fibronectin and
D) vimentin. MDA-MB-468-EMT cells show reduced non-stimulated Ca
2+ influx, shown as E) average cytosolic Ca
2+ response, F) peak relative Ca
2+
influx (peak 2) and G) ratio of Ca
2+ influx amplitude (peak 2) divided by AUC (t=0–705 s). Values show mean 6 S.D. for nine wells from three
independent experiments. * P,0.05 (unpaired t-test).
doi:10.1371/journal.pone.0036923.g002
TRPC1 and ORAI1 in MDA-MB-468 Cells
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2+ entry with EGF-
induced EMT. Similar reductions in agonist-stimulated Ca
2+ entry
were observed with the protease-activated receptor-2 (PAR-2)
activator trypsin (Fig. 3D–F) as well as a reduction in store-
operated Ca
2+ entry as assessed with the SERCA inhibitor CPA
(Fig. 3G–I).
To examine the nature of the [Ca
2+]CYT responses we
quantified the time to reach peak [Ca
2+]CYT levels after ATP,
trypsin and CPA addition (Fig. 3J–L). A modest but significant
difference in the time to peak was observed with ATP-mediated
purinergic receptor activation (40.461.9 s versus 48.164.0 s;
P,0.05); this may be explained by altered purinergic-mediated
signaling with EGF-induced EMT, as previously reported [19]. No
change in the time to reach peak [Ca
2+]CYT was observed with
trypsin-activation. However, a pronounced delay was seen in the
time taken to reach peak [Ca
2+]CYT with CPA treatment in MDA-
MB-468 cells after EMT induction (154.7618.8 s versus
216.6637.8 s; P,0.05). These results are reflective of a substantial
change in the nature of the response to CPA, and altered ER Ca
2+
homeostasis associated with EGF-induced EMT.
ORAI1 and TRPC1 mRNA levels in MDA-MB-468 cells with
EGF-induced EMT
We assessed whether reductions in Ca
2+ influx with EGF-
induced EMT were associated with reduced mRNA levels of
TRPC1 and ORAI1 channels. No change in TRPC1 mRNA
levels was observed with EGF-induced EMT (Fig. 4A). However, a
modest (,2-fold) increase in ORAI1 mRNA levels (Fig. 4B) was
observed. This is consistent with previous studies showing elevated
ORAI1 expression with TGFb-induced EMT in MCF7 cells [20],
but does not explain the significantly reduced store-operated Ca
2+
entry shown in MDA-MB-468-EMT cells.
ORAI1 and TRPC1 silencing attenuates non-stimulated
calcium influx in MDA-MB-468 breast cancer cells
Given that changes in non-stimulated, agonist-stimulated and
store-operated Ca
2+ entry with EGF-induced EMT may reflect
changes in ORAI1 or TRPC1 protein expression and/or function,
we assessed whether siRNA-mediated inhibition of these two ion
channels could phenocopy the changes in Ca
2+ homeostasis
observed with EGF-induced EMT.
Silencing of both ORAI1 (siORAI1) and TRPC1 (siTRPC1)
(Fig. 5) inhibited non-stimulated Ca
2+ influx compared to the non-
targeting control (siNT) in MDA-MB-468 cells (Fig. 6A–C). These
results demonstrate a role for both of these channels in non-
stimulated Ca
2+ influx in MDA-MB-468 cells.
Consequences of ORAI1 and TRPC1 silencing on agonist-
stimulated and store-operated calcium entry
Silencing of ORAI1 inhibited ATP-stimulated Ca
2+ entry in
MDA-MB-468 breast cancer cells (Fig. 6D). Quantitation of Ca
2+
influx (peak 2 relative [Ca
2+]CYT response) (Fig. 6E) and the ratio
of peaks (Fig. 6F) showed significant inhibition of ATP-stimulated
Ca
2+ entry with siORAI1. Silencing of TRPC1 produced a modest
but significant increase in Ca
2+ influx (peak 2 relative [Ca
2+]CYT
response), however, this effect was associated with increased ATP-
mediated Ca
2+ store release (peak 1) and so was not associated
with alterations in agonist-stimulated Ca
2+ entry as assessed by the
peak ratio (Fig. 6F). Similar to ATP, agonist-stimulated Ca
2+ entry
mediated by trypsin was greatly attenuated by ORAI1 siRNA
(Fig. 6G–I). TRPC1 silencing augmented the peak 2 [Ca
2+]CYT
response (Fig. 6H); this was associated with a modest but
significant decrease in trypsin-stimulated Ca
2+ entry as assessed
by the peak ratio (Fig. 6I). Only ORAI1 siRNA inhibited store-
operated Ca
2+ entry mediated by Ca
2+ store-depletion using CPA
(Fig. 6J–L). These results suggest that activation of some receptors
(e.g., PAR-2) may recruit both ORAI1 and TRPC1 (although to a
Figure 3. Agonist-stimulated and store-operated Ca
2+ entry in MDA-MB-468 cells with EGF-induced EMT. Average cytosolic Ca
2+
response, peak relative Ca
2+ influx (peak 2) and ratio of Ca
2+ influx amplitude (peak 2) divided by AUC (t=0–705 s) mediated by 100 mM ATP (A–C),
30 nM trypsin (D–F) and 10 mM CPA (G–I). Average time to peak (t=0–705 s) for J) ATP, K) trypsin and L) CPA. Values show mean 6 S.D. for nine
wells from three independent experiments; * P,0.05 (unpaired t-test).
doi:10.1371/journal.pone.0036923.g003
Figure 4. mRNA levels of TRPC1 and ORAI1 with EGF-induced
EMT. TRPC1 (A) and ORAI1 (B) mRNA levels in MDA-MB-468 breast
cancer cells stimulated with EGF to induce EMT. Values show mean 6
S.D. for nine wells from three independent experiments; * P,0.05
(unpaired t-test).
doi:10.1371/journal.pone.0036923.g004
Figure 5. siRNA-mediated silencing of ORAI1 and TRPC1 in
MDA-MB-468 breast cancer cells. A) Quantitation of TRPC1 mRNA
expression 48 h after treatment with TRPC1 siRNA (siTRPC1) relative to
the non-targeting siRNA control (siNT). B) Assessment of ORAI1
expression 48 h post transfection with ORAI1 siRNA (siORAI1). Values
show mean 6 S.D. for six wells from three independent experiments; *
P,0.05 (unpaired t-test).
doi:10.1371/journal.pone.0036923.g005
TRPC1 and ORAI1 in MDA-MB-468 Cells
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breast cancer cells, whereas other mechanisms are specific for
ORAI1 over TRPC1, such as ATP and store-depletion as a
consequence of SERCA inhibition.
Silencing of TRPC1 changes the nature of the [Ca
2+]CYT
response associated with SERCA inhibition
MDA-MB-468 cells with TRPC1 knockdown exhibited a delay
in the time to reach peak [Ca
2+]CYT with CPA stimulation (Fig. 6J
& Fig. 7). This effect was remarkably similar to the change in CPA
response observed during EGF-induced EMT (Fig. 3G & L). In
contrast ORAI1 silencing did not alter the nature of the CPA
response in these cells. The change in Ca
2+ leak from the ER upon
SERCA inhibition in MDA-MB-468 cells with TRPC1 silencing
suggests that TRPC1 is a direct regulator of Ca
2+ homeostasis in
the ER.
TRPC1 silencing inhibits constitutively active ERK1/2 and
leads to S-phase reduction
As ORAI1 [11] and TRPC1 [25] regulate ERK1/2 activity in
other cell types we assessed constitutive ERK1/2 phosphorylation
in MDA-MB-468 breast cancer cells with ORAI1 or TRPC1
silencing. Knockdown of ORAI1 had no effect on constitutive
ERK1/2 activity in these cells; however, silencing of TRPC1
channels led to a pronounced reduction in constitutively active
ERK1/2 in MDA-MB-468 breast cancer cells (Fig. 8A & B).
Sustained ERK1/2 phosphorylation can regulate S-phase entry
[26]. Therefore, we assessed whether TRPC1-mediated inhibition
of constitutive ERK1/2 activity in MDA-MB-468 breast cancer
cells led to reduced cell count and S-phase reduction. Compared
to the non-targeting siRNA control, MDA-MB-468 breast cancer
cells with TRPC1 silencing showed modest but significant
reductions in cell number (Fig. 8C-DAPI and Fig. 8D) and a
reduced percentage of cells in the S-phase of the cell cycle (Fig. 8C-
EdU and Fig. 8E). Together our findings indicate that TRPC1
silencing in MDA-MB-468 cells reduces the pool of constitutively
active ERK1/2 and reduces cell proliferation.
Discussion
Altered Ca
2+ influx is a feature of many epithelial cancers,
including breast, prostate and ovarian cancer, and may regulate
processes important for carcinogenesis [27,28]. Examples of the
significance of Ca
2+ influx in cancer include the up-regulation of
T R P C 3c h a n n e l si nh u m a no v a r i a nc a n c e r s ,a n dt h ea b i l i t yo f
TRPC3 knockdown to inhibitgrowth factor-mediated Ca
2+ signaling
and cell cycle progression in SKOV3 ovarian cancer cells [29].
Molecularcomponentsofthe store-operatedCa
2+entry pathway also
regulate cell signaling events important in carcinogenesis, the best
characterized of which is ORAI1-mediated activation of the Ca
2+-
dependent transcription factor NFAT [30]. Recent studies show that
regions of the Ca
2+ pump SPCA2 can activate ORAI1 and promote
constitutive Ca
2+ influx and phospho-protein signaling in MCF7
breast cancer cells, independently of Ca
2+ store depletion [11]. Here
we characterized Ca
2+ influx,in particularmechanismsimportant for
store-operated Ca
2+ entry, during EGF-mediated EMT in human
breast cancer cells and the downstream signaling events regulated by
these Ca
2+ influx pathways. Table 1 summarizes changes in Ca
2+
homeostasis characterized in this study.
Ca
2+ influx following Ca
2+ store depletion mediated by either
agonist-stimulation (with ATP) or via inhibition of SERCA activity
(with CPA) was assessed in two phenotypically distinct breast cancer
cell lines—MDA-MB-468 and MDA-MB-231. Both cell lines
demonstrated Ca
2+ influx via ATP-stimulated and store-operated
Ca
2+ entry. Surprisingly MDA-MB-468 breast cancer cells also
s h o w e dp r o n o u n c e dC a
2+ influx in the absence of agents to deplete
ER Ca
2+ reserves. This non-stimulated Ca
2+ influx is not a universal
characteristic of breast cancer cell lines [13], and may reflect a
proclivity of MDA-MB-468 cells to undergo EMT. MDA-MB-468-
EMT cells, characterized by elevated expression of a panel of
mesenchymal markers, showed a reduced level of non-stimulated
Ca
2+ influx. These results suggest that in addition to a remodeling of
purinergic receptor-mediated Ca
2+ signaling [19], EGF-induced
EMT in MDA-MB-468 breast cancer cells is associated with a
significant reduction in non-stimulated Ca
2+ influx. EGF-induced
EMT in MDA-MB-468 breast cancer cells was also associated with
reduced agonist-stimulated and store-operated Ca
2+entry, in contrast
with a recent study by Hu et al. [20], showing elevated store-operated
Ca
2+ entry with TGFb-induced EMT in MCF7 breast cancer cells.
Further studies are therefore required to determine how store-
operated Ca
2+entry changes in other cancer cell lines and using other
methods to induce EMT, for example hypoxia or via the expression
of EMT-inducing transcription factors [31,32].
An array of Ca
2+-permeable ion channels are implicated in
constitutive Ca
2+ influx, including TRP channels with reported
basal activity (e.g., TRPV6) [33,34] and ORAI channels [11].
Here we show that in MDA-MB-468 breast cancer cells, both
ORAI1 and TRPC1 silencing reduce non-stimulated Ca
2+ influx;
suggesting that altered activity of these channels may be a feature
of EGF-induced EMT. Mechanistically, the many activators of
ORAI1, including STIM1 and 22 [8,9,35,36], and SPCA2 [11],
may contribute to an ORAI1-mediated reduction in non-
Figure 6. Effect of TRPC1 and ORAI1 silencing on Ca
2+ influx pathways in MDA-MB-468 breast cancer cells. Non-stimulated Ca
2+ influx
was assessed in MDA-MB-468 breast cancer cells with ORAI1 silencing (siORAI1) or TRPC1 silencing (siTRPC1); A) average cytosolic Ca
2+ response, B)
peak relative Ca
2+ influx (peak 2) and C) ratio of Ca
2+ influx amplitude (peak 2) divided by AUC (t=0-705 s). The role of ORAI1 and TRPC1 in agonist-
stimulated Ca
2+ entry, mediated by 100 mM ATP (D–F) and 30 nM trypsin (G–I), and store-operated Ca
2+ entry with 10 mM CPA (J–L) was assessed.
Data show mean 6 S.D. for nine wells from three independent experiments; * P,0.05 (one-way ANOVA with Bonferroni post-tests).
doi:10.1371/journal.pone.0036923.g006
Figure 7. Altered ER Ca
2+ release kinetics with TRPC1 silencing.
Quantitation of the time to reach peak cytosolic Ca
2+ (t=0–705 s) with
CPA in MDA-MB-468 cells with ORAI1 or TRPC1 silencing. Values show
mean 6 S.D. for nine wells from three independent experiments; *
P,0.05 (one-way ANOVA with Bonferroni post-tests).
doi:10.1371/journal.pone.0036923.g007
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2+ influx. Reduced non-stimulated influx via TRPC1
may also arise through multiple mechanisms such as altered gene
expression, channel gating [37], localization [38] or heteromulter-
ization [39,40]. A transcriptional down-regulation of ORAI1 or
TRPC1 does not appear to be involved, as no significant reduction
in ORAI1 or TRPC1 expression was observed in MDA-MB-468
cells with EGF-induced EMT. Further studies are required to
determine how ORAI1 and TRPC1 may be altered with EGF-
induced EMT and to investigate possible changes in other Ca
2+
influx pathways during this phenotypic switch.
In addition to these channel-specific mechanisms of regulation,
control of non-stimulated Ca
2+ influx may depend on a complex
interplay between TRPC1 and ORAI1 channels. The 93%
inhibition of non-stimulated Ca
2+ influx by ORAI1 knockdown
would suggest that other plasma membrane Ca
2+ channels make
up only a small (,7%) component of non-stimulated Ca
2+ influx.
However, TRPC1 knockdown inhibited non-stimulated Ca
2+
influx by more than 50%. These results suggest that TRPC1
and ORAI1 cooperate to regulate non-stimulated Ca
2+ influx, and
that TRPC1-mediated regulation of non-stimulated Ca
2+ influx is
dependent on Ca
2+ influx through ORAI1 channels.
Figure 8. Effect of TRPC1 and ORAI1 silencing on constitutive ERK1/2 activity and cell proliferation. A) Representative immunoblot
showing constitutive phosphorylation and total expression of ERK1/2 in MDA-MB-468 cells with ORAI1 or TRPC1 silencing. B) Densitometric data was
obtained from the pooled data (three independent immunoblots) and shows ERK1/2 phosphorylation relative to total ERK1/2 expression; * P,0.05
(one-way ANOVA with Bonferroni post-tests). C) DAPI (cell number) and EdU staining (showing cells in S-phase of the cell cycle). D) Quantitation of
the average cell count and (E) EdU positivity for nine wells from three independent experiments.* P,0.05 (unpaired t-test). All graphs show mean 6
S.D. Scale bar represents 100 mm.
doi:10.1371/journal.pone.0036923.g008
Table 1. Summary of changes in Ca
2+ homeostasis with EGF-
induced EMT and silencing of ORAI1 (siORAI1) or TRPC1
(siTRPC1).
Epithelial MesenchymalsiORAI1 siTRPC1
Non-stimulated
Ca
2+ influx
qQ QQ
Agonist-
stimulated Ca
2+
entry
qQ Q« or Q
Store-operated
Ca
2+ entry
qQ Q«
ER Ca
2+ release Fast Slow « Slow
Arrows signify whether the epithelial, mesenchymal or knockdown phenotypes
are associated with a significant increase (q) or decrease (Q) or no change («)
in Ca
2+ influx via each pathway. Changes in the release of ER Ca
2+ upon SERCA
inhibition are described as fast, slow or unchanged («) for each condition.
doi:10.1371/journal.pone.0036923.t001
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with significant delays in the time to reach peak [Ca
2+]CYT after
SERCA inhibition, providing some evidence for a role for TRPC1
in the regulation of resting ER Ca
2+. Such a result can be
explained by the cellular expression of TRPC1 at sites other than
the plasma membrane. A non-plasmalemmal distribution for
TRPC1 has been shown in human salivary gland cells [41].
Furthermore, TRPC1 channels have been shown to localize to the
sarcoplasmic reticulum (SR) of muscle fibres and regulate SR Ca
2+
leak [42], and mis-localization of TRPC1 to the ER can occur
when TRPC1 is overexpressed in epithelial cells [39,40,43]. The
existence of functional intracellular TRPC1 channels on the ER is
still controversial, owing to the lack of specific TRPC1 antibodies
[44,45] and inherent problems related to channel localization in
overexpression systems. However, ER-resident TRPC1 Ca
2+
channels may promote ER Ca
2+ leak, similar to the increased
Ca
2+ leak reported with ER-localized TRPP2 Ca
2+ channels in
kidney cells [46], and ER Ca
2+ leak regulated by Bcl-2 [47,48].
Mislocalization of TRP channels is also seen in cancer cells
[49,50], with the expression of functional TRPM8 channels on the
ER of prostate cancer cells [50]. TRPC1-mediated ER Ca
2+ leak
would trigger Ca
2+ influx via ORAI1 to replenish lower ER Ca
2+
reserves. Therefore, the non-stimulated Ca
2+ influx observed in
MDA-MB-468 breast cancer cells, which is sensitive to both
TRPC1 and ORAI1 knockdown, may be due to enhanced ER
Ca
2+ leak through TRPC1, the consequence of which is increased
store-regulated Ca
2+ influx through ORAI1.
Ca
2+ entry following depletion of ER Ca
2+ stores with CPA
(SERCA inhibitor) or following activation of PAR-2 or purinergic
receptors was greatly inhibited in cells with ORAI1 silencing.
While a critical role for ORAI1 in store-operated Ca
2+ entry is
widely accepted, the role of TRPC1 in this process is controversial
[4,41,43,51]. Although in our study TRPC1 knockdown produced
modest reductions in trypsin-stimulated Ca
2+ entry, the absence of
pronounced changes in Ca
2+ influx following store depletion with
CPA indicates that TRPC1 is not a regulator of store-operated
Ca
2+ entry in MDA-MB-468 breast cancer cells under these
conditions. These findings are consistent with studies in vascular
smooth muscle cells, where silencing of TRPC1 had no effect on
store-operated Ca
2+ entry [18].
Rather than acting as a store-operated Ca
2+ entry channel per se,
we provide evidence for a model in MDA-MB-468 cells whereby
TRPC1-indirectly activates Ca
2+ influx via ORAI1 in a highly
contextual manner. Basal ER Ca
2+ leak, which could be in-part
mediated by ER-localized TRPC1, would create a requirement for
Ca
2+ influx mediated by ORAI in MDA-MB-468 cells (non-
stimulated Ca
2+ influx). However, under conditions that produce
large reductions in ER Ca
2+ (e.g., SERCA inhibition with
extracellular Ca
2+ chelation), the contribution of TRPC1 to
Ca
2+ influx may be masked by maximal ORAI1 activation.
Differences in the functional consequences of ORAI1 and
TRPC1 knockdown in MDA-MB-468 cells were also reflected in
effects on constitutive ERK1/2 phosphorylation. Knockdown of
ORAI1 in MDA-MB-468 breast cancer cells had no effect on the
level of constitutively active ERK1/2. This is in contrast to MCF7
breast cancer cells, where ORAI1 silencing almost completely
abolishes constitutive ERK1/2 activity [11]. Differences in the
regulation of ERK1/2 between breast cancer cell lines is not
unexpected given the cell-type and context-specific nature of this
signal; its spatiotemporal regulation; and the complexity of
upstream phospho-protein regulation [52]. In MDA-MB-468
breast cancer cells, silencing of TRPC1 was associated with a
marked reduction in constitutive ERK1/2 activity. Differential
regulation of ERK1/2 by TRPC1 (but not ORAI1) suggests that
constitutive ERK1/2 signaling in MDA-MB-468 cells is not
regulated by global increases in [Ca
2+]CYT, as both agents reduced
non-stimulated Ca
2+ influx. Given that both ERK and upstream
Ras-GTPases may localize to the ER membrane [53,54],
regulation of constitutive ERK1/2 signaling in MDA-MB-468
cells may be dependent on TRPC1 channels also located on the
ER membrane and/or the nature of the Ca
2+ signal regulated by
TRPC1.
To explore the possible consequences of TRPC1-mediated
reductions in ERK1/2 signaling, we assessed cell proliferation in
MDA-MB-468 breast cancer cells with TRPC1 silencing. Recent
studies show that sustained (but not transient) ERK1/2 activation
is a regulator of S-phase entry in NIH3T3 mouse embryonic
fibroblasts [26]. MDA-MB-468 breast cancer cells with TRPC1
silencing showed reduced cell number and the percentage of cells
in the S-phase of the cell cycle. These results indicate that Ca
2+
signaling via TRPC1 regulates a constitutive ERK1/2 phosphor-
ylation and cell proliferation in MDA-MB-468 cells breast cancer
cells.
The current study has characterized mechanisms regulating
Ca
2+ influx in MDA-MB-468 human breast cancer cells and
assessed alterations in Ca
2+ signaling as a consequence of EGF-
induced EMT. MDA-MB-468 breast cancer cells in the epithelial
state have a high degree of non-stimulated Ca
2+ influx through
ORAI1, potentially due to alterations in ER Ca
2+ reserves. Our
studies suggest that some of the disparities in the reported roles for
TRPC1 in store-operated Ca
2+ entry may be explained by the
context-specific signaling of these channels (i.e., cellular localiza-
tion, the degree of Ca
2+ store depletion and non-stimulated Ca
2+
influx); factors which are likely to vary between cell types and
experimental conditions. Our studies also define a specific role for
TRPC1 in the regulation of the constitutively active pool of
ERK1/2 in MDA-MB-468 cells. Given the potential for Ca
2+ to
regulate processes important in carcinogenesis [28], and the
identification of TRPC1 as a regulator of protein kinases, it is now
imperative to establish the cellular localization of Ca
2+ channels in
cancer cells, and the molecular mechanisms governing their
cellular distribution.
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